Latest News

With $1.6B Mazor Robotics buy, Medtronic Spine hits reset button

An expensive failed acquisition, sales force flux, off-label use of a controversial biologics product, a DOJ investigation and nimble competitors chipping away has hobbled Medtronic’s spine business. The purchase of Mazor Robotics aims to be a major reset.

Related posts

Russian, Indian scientists express concern over sharp rise in autism cases


When coronavirus kills, the lung condition ARDS can be the culprit. Here's what you need to know.


The significance of scope in modelling tones in Chinese


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy